ArticleFrontiers in immunology2025

A20 mRNA therapeutics ameliorate systemic sclerosis by suppressing TRAF-6/NF-KB signaling and DREAM expression and exerting antifibrotic effects.

A Ram Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.